Hepion Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.21
|
0.00
|
0.21
|
100.00%
|
|
2022-12-31
|
-0.18
|
0.00
|
0.18
|
100.00%
|
|
2022-09-30
|
-0.17
|
-0.11
|
0.06
|
35.29%
|
|
2022-06-30
|
-0.12
|
-0.26
|
-0.14
|
-116.67%
|
|
2022-03-31
|
-0.12
|
-0.13
|
-0.01
|
-8.33%
|
|
2021-12-31
|
-0.13
|
-0.13
|
-0.01
|
-4.00%
|
|
2021-09-30
|
-0.19
|
-0.12
|
0.07
|
36.84%
|
|
2021-06-30
|
-0.19
|
-0.10
|
0.09
|
47.37%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.50
|
|
2021-12-31
|
-0.47
|
|
2020-12-31
|
-2.09
|
|
2019-12-31
|
-9.05
|
|
2018-12-31
|
-80.58
|
|
2017-12-31
|
-56.72
|
|
2016-12-31
|
-3.18
|
|
2015-12-31
|
-1.11
|
|
2014-12-31
|
-461.71
|